Pediatric (Non-CNS) Tumors
This chapter will discuss management of pediatric tumors including Wilms’ tumor, neuroblastoma, rhabdomyosarcoma, Ewing’s sarcoma, pediatric Hodgkin’s lymphoma, and retinoblastoma.
KeywordsWilms’ tumor Neuroblastoma Rhabdomyosarcoma Ewing’s sarcoma Pediatric Hodgkin’s lymphoma Retinoblastoma
We thank Stuart Y. Tsuji MD, PhD, and Linda W. Chan, MD, for their work on the prior edition of this chapter.
- Cheung NV, Cheung IY, Kushner BH, et al. Murine anti-GD2 monoclonal antibody 3F8 combined with granulocyte-macrophage colony-stimulating factor and 13-cis-retinoic acid in high-risk patients with stage 4 neuroblastoma in first remission. J Clin Oncol. 2012;30(26):3264–70.CrossRefPubMedPubMedCentralGoogle Scholar
- Park JR, Kreissman SG, London WB, et al. A phase 3 randomized clinical trial of tandem myeloablative autologous stem cell transplant using peripheral blood stem cell as consolidation therapy for high-risk neuroblastoma: a children’s oncology group study. 2016 ASCO Annual Meeting. Abstract LBA3. 2016.Google Scholar
- Peifer M, Hertwig F, Roeis F, et al. Telomerase activation by genomic rearrangements in high-risk neuroblastoma. Nature. 2015;526(7575):700–4.Google Scholar
- Arndt CA, Stoner JA, Hawkins DS, et al. Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children’s oncology group study D9803. J Clin Oncol. 2009;27(31):5182–8.CrossRefPubMedPubMedCentralGoogle Scholar
- Talleur AC, Navid F, Spunt SL, McCarville MB, Wu J, Mao S, Davidoff AM, Neel MD, Krasin MJ. Limited margin radiation therapy for children and young adults with Ewing sarcoma achieves high rates of local tumor control. Int J Radiat Oncol Biol Phys. 2016;96(1):119–26.CrossRefPubMedPubMedCentralGoogle Scholar
Pediatric Hodgkin’s Lymphoma
- Friedman DL, Chen L, Wolden S, et al. Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk Hodgkin lymphoma: A report from Children’s Oncology Group Study AHOD0031. J Clin Oncol. 2014;32(32):3651–8.CrossRefPubMedPubMedCentralGoogle Scholar